Kane Biotech Inc. KNE.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 601.90K | 283.00K | 657.60K | 674.20K | 1.18M |
| Total Receivables | 28.40K | 21.10K | 26.60K | 94.20K | 102.00K |
| Inventory | 338.30K | 341.50K | 368.00K | 243.40K | 245.30K |
| Prepaid Expenses | 139.10K | 196.10K | 179.80K | 188.40K | 220.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.11M | 841.70K | 1.23M | 1.20M | 1.75M |
|
|
|||||
| Total Current Assets | 1.11M | 841.70K | 1.23M | 1.20M | 1.75M |
| Net Property, Plant & Equipment | 58.60K | 63.30K | 347.50K | 359.60K | 626.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 402.80K | 392.30K | 414.50K | 407.80K | 417.90K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.57M | 1.30M | 1.99M | 1.97M | 2.79M |
|
|
|||||
| Total Accounts Payable | 817.50K | 868.90K | 505.40K | 887.80K | 760.80K |
| Total Accrued Expenses | -- | -- | 279.50K | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 917.40K | 916.10K | 966.80K | 446.20K | 390.00K |
| Total Finance Division Other Current Liabilities | 69.10K | 71.00K | 73.00K | -- | 303.70K |
| Total Other Current Liabilities | 69.10K | 71.00K | 73.00K | -- | 303.70K |
| Total Current Liabilities | 1.80M | 1.86M | 1.82M | 1.33M | 1.45M |
|
|
|||||
| Total Current Liabilities | 1.80M | 1.86M | 1.82M | 1.33M | 1.45M |
| Long-Term Debt | 465.00K | 457.50K | 450.10K | 944.00K | 1.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 263.70K | 259.10K | 508.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.27M | 2.31M | 2.54M | 2.54M | 2.97M |
|
|
|||||
| Common Stock & APIC | 26.31M | 26.09M | 26.53M | 25.69M | 26.20M |
| Retained Earnings | -27.24M | -27.12M | -27.08M | -26.27M | -26.38M |
| Treasury Stock & Other | 226.40K | 10.40K | 10.60K | 10.40K | 10.60K |
| Total Common Equity | -699.90K | -1.02M | -544.50K | -569.60K | -172.30K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -699.90K | -1.02M | -544.50K | -569.60K | -172.30K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -699.90K | -1.02M | -544.50K | -569.60K | -172.30K |
|
|
|||||